Blood Test Shows Promise for Early Detection of Colorectal Cancer

A recent study published in the New England Journal of Medicine reports a DNA blood-based test that identified 83% of patients with colorectal cancer. This test is showing promise as a new option for colorectal cancer screening. Samir Gupta, MD,…

Moncrief Cancer Institute debuts new Mobile Screening Clinic funded by Tarrant County

Moncrief Cancer Institute debuted its new Mobile Screening Clinic prior to the Tarrant County Commissioners Court meeting today. The $1 million, 36-foot cancer screening clinic was funded by Tarrant County through a three-year, $9 million grant awarded to Moncrief Cancer Institute in 2022. Part of the federal funding Tarrant County received through the American Rescue Plan Act (ARPA), the grant enabled Moncrief to expand its comprehensive cancer screening program to more underserved residents in Tarrant County.

UCLA Health expert available to discuss colorectal cancer screening, the increase in colorectal cancer in young adults, and more during Colorectal Cancer Awareness Month

  UCLA Health expert available to discuss colorectal cancer screening, the increase in colorectal cancer in young adults, and more during Colorectal Cancer Awareness Month Folasade May, MD, PhD, UCLA Health colon cancer prevention researcher and gastroenterologist, is available for interview on a variety…

World Cancer Day is February 4th. Ochsner Health oncologist available to stress the importance of cancer screenings and early detection.

It is well known that early detection is key to navigating a cancer diagnosis. As we all continue to work our way toward post-pandemic times, there is still significant concern that many have pushed off these vital screenings. February 4th…

UTHealth Houston study: Lower cancer screening rates differ by region, tied to social vulnerability

Populations in U.S. counties defined as more vulnerable based on social factors including socioeconomic status and racial/ethnic minority status were significantly less likely to receive timely breast, cervical, and colorectal cancer screenings, according to research from UTHealth Houston.

Study Finds COVID-19 Pandemic Reduced Breast, Cervical, Colorectal Cancer Screenings by Millions in 2020

New findings led by researchers at the American Cancer Society show the number of women in the United States who reported having a recent (in the past year) breast cancer or cervical cancer screening dropped by 2.13 million (6%) and 4.47 million (11%) respectively in 2020 compared to 2018. The study is the first of its kind to evaluate the impact of the COVID-19 pandemic on cancer screenings nationally using population-based data.

Leading Cancer Organizations Warn Cancer Doesn’t Stop for COVID-19 and Neither Should You

The National Comprehensive Cancer Network (NCCN) and the American Cancer Society (ACS) are teaming up with leading cancer organizations across the country to endorse prioritizing the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic. The coalition of 76 organizations is releasing an open letter about the threat cancer still poses to people’s health and a reminder that acting as soon as is safely possible can lead to much better outcomes in the future.

COVID-19 Impacted Breast Cancer Screening, Health Disparities Continue

UC San Diego Health experts available to discuss these and related topics during Breast Cancer Awareness Month  Mammography is the most effective tool for screening breast cancer, using X-rays to identify abnormalities in breast tissues. Although health care facilities saw…